Healthcare Services

Flow Cytometry In Oncology And Immunology Market Growth Forecast With Analysis Of Industry Progress Through 2030

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Flow Cytometry In Oncology And Immunology Market Increase Between 2026 And 2030?

The flow cytometry in oncology and immunology market size has experienced rapid expansion in recent years. It is forecast to grow from $2.32 billion in 2025 to $2.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.2%. This historical growth can be linked to several factors, including an increase in cancer research funding, the progression of immunotherapy development, the availability of advanced cytometry platforms, a rise in clinical trial activity, and the growing necessity for immune monitoring.

The flow cytometry in oncology and immunology market size is projected to undergo significant expansion in the coming years. It is foreseen to reach $3.82 billion by 2030, progressing at a compound annual growth rate (CAGR) of 10.5%. The projected increase in this period can be attributed to the growing demand for personalized oncology diagnostics, the integration with genomic data, the proliferation of immuno-oncology therapies, the expansion of clinical research pipelines, and advancements in multiplex analysis. Prominent trends within the forecast period include the increasing application in cancer biomarker identification, greater adoption in immune cell profiling, the broadening of minimal residual disease detection, an expanding role in translational research, and the incorporation of high-dimensional data analysis.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

What Important Drivers Are Powering The Flow Cytometry In Oncology And Immunology Market Growth?

The increasing prevalence of HIV/AIDS is projected to boost the expansion of flow cytometry within the oncology and immunology market in the coming years. HIV, a virus, targets the body’s immune system, specifically CD4 cells, which are vital white blood cells essential for combating infections. If left untreated, HIV can progress to AIDS, representing the final stage of HIV infection. Flow cytometry stands as a robust technique employed in both HIV/AIDS research and clinical environments to analyze and describe cells, particularly immune cells, based on their inherent physical and chemical characteristics. This technique is capable of pinpointing latently infected T cells that contain the HIV genome but are not actively generating the virus. As an illustration, in July 2024, UNAIDS, a UN program based in Switzerland, reported that approximately 39.9 million individuals worldwide were living with HIV in 2023, an increase from 39.0 million in 2022. Consequently, the increasing prevalence of HIV/AIDS is propelling the flow cytometry in the oncology and immunology market.

How Is The Flow Cytometry In Oncology And Immunology Market Distributed Across Key Segments?

The flow cytometry in oncology and immunology market covered in this report is segmented –

1) By Type: Immunology, Oncology

2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry

3) By Application: Translational Research, Clinical Research

4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Subsegments:

1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing

2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation

Which Trends Are Supporting The Evolution Of The Flow Cytometry In Oncology And Immunology Market?

Major companies operating in the flow cytometry within the oncology and immunology market are concentrating on creating innovative solutions, such as spectral flow cytometry, to secure a competitive advantage. Spectral flow cytometry is a technology that captures the complete emission spectrum of each fluorescent marker rather than detecting fixed, narrow-band signals, enabling much higher parameter, multiparametric cell analysis. For instance, in May 2024, Agilent Technologies, a US-based life science company, introduced the NovoCyte Opteon spectral flow cytometer. This system supports three to five lasers, has up to 73 detectors, and enables analysis of more than 40 markers in a single run. The introduction of this system enhances the capacity for deep immunophenotyping in oncology and immunology research. Its advantages include flexibility in panel design, reduced spectral overlap, and improved signal resolution; however, it requires more complex data unmixing algorithms, potentially increasing analysis time.

Which Firms Are Competing In The Flow Cytometry In Oncology And Immunology Market?

Major companies operating in the flow cytometry in oncology and immunology market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, Miltenyi Biotec, Luminex Corporation, Q2 Solutions LLC, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason

Access The Complete Flow Cytometry In Oncology And Immunology Market Report:

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Which Region Has The Strongest Presence In The Flow Cytometry In Oncology And Immunology Market?

North America was the largest region in the flow cytometry in oncology and immunology market in 2025. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Flow Cytometry In Oncology And Immunology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12469&type=smp

Browse Through More Reports Similar to the Global Flow Cytometry In Oncology And Immunology Market 2026, By The Business Research Company

Flow Cytometry In Oncology And Immunology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Flow Chemistry Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-chemistry-global-market-report

Lateral Flow Assays Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lateral-flow-assays-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795